| Diseases Home | Blood Disorders | Digestive Disorders | Eye Disorders | Gynacological Diseases | Skin Disorders | Cardiovascular Diseases | Nerve Disorders | Diseases Index A-Z | Medicines & Drugs |
|
|
|||||||||
|
|
|||||||||
|
||||||||||
|
||||||||||
Kaposis Sarcoma - symptom, Treatment of Kaposis SarcomaKaposis Sarcoma InformationKaposi's sarcoma is a form of skin cancer that can involve internal organs. The etiology of KS remains unknown, but evidence suggests that the disease is promoted by the effects of immunosuppression and immune activation, possibly combined with a sexually transmissible infectious agent. This diseases is is more likely to afflict men than women suggests sex hormones, such as testosterone in men, may stimulate the growth of KS tumors, and that estrogen in women may retard their growth. There are four main types of KS They are all more common in men than women.
Symptoms of Kaposis SarcomaKaposi's sarcoma produces pink, purple, or brown tumors on the skin, mucous membranes, or internal organs. KS can also affect other parts of the body, most commonly the lymph nodes, the lungs and the organs of the digestive system. KS most commonly involves the skin, although involvement of the lymph nodes, the oral cavity, and gastrointestinal tract are often seen at presentation. Causes of Kaposis SarcomaA variety of factors appear to contribute to the development of KS. Most KS is now believed to be caused by a virus called Human Herpes Virus 8 (HHV8), which is also known as Kaposi's Sarcoma-associated Herpes Virus (KSHV). The virus can be passed on through sexual contact, kissing, blood transfusions and organ transplantation. Treatment of Kaposis SarcomaIf a diagnosis of KS is confirmed, further tests are usually done to see if there are any signs of KS cells elsewhere in your body. Therapeutic approaches must take into account that there is no curative therapy, that the natural course of the disease may be quite variable and that a large number of systemic approaches have immunosuppressive effects. A trial is currently underway to evaluate low-dose oral etoposide for the treatment of relapsed or progressed KS after systemic chemotherapy. |
Fever fever with Rash Filariasis Fibroid Focal Neurological Deficit Floaters Food Poisoning - Bacterial Folliculitis Foot Pain Bone Fracture Gall Bladder Gangrene German Measles Glomerulus Huntingtons Disease Hypersomnia Heart Disease In Pregnancy Hepatitis Insomnia Infertility Influenza Irritable Bowel Syndrome Ischemic Heart Disease Intussusception Intrauterine Growth Retardation Injury Inguninal Hernia Infertility Infectious Arthritis Impetigo Jaundice Joint Pains Kleptomania Kidney Failure Kerosene Poisning Kyphosis Keratitis Kaposis Sarcoma Lacunar Stroke Leriches Syndrome Lacunar Infarction Leucorrhoea Laryngitis Liver Failure Liver Toxidity Lumber Puncture Leukemia Acute Laryngeal Cancer Legionnaires Disease Labyrinthitis Monoclonal Gammopathy Myelofibrosis Malaria Measles Mediastinitis Megalobastic Anemia Melanoma Menieres Disease Meningtis Menopause Menstruation Mesothelioma Metabolic Acidosis Mononucleosis Mouth Ulcers Mouth Discolouration Multiple Pregnancy Multiple Sclerosis Mumps Myasthenia Gravis Myocardial Infarction Myocarditis Piedra Polycythemia Vera Pyromania Tinea Versicolor Tinea negra Trichotillomania Trichomycosis Axillaris Thrombocythemia |
|
|
|||||
 |
|
|
 |
|
|